Mativ (MATV) CEO Shruti Singhal awarded 125,159 time-vested RSUs

Rhea-AI Filing Summary

Mativ Holdings, Inc. reported that President and CEO Shruti Singhal acquired 125,159 Restricted Stock Units (RSUs) on February 24, 2026 as an equity award. These RSUs are subject to time-based vesting in three equal annual installments on February 24, 2027, February 24, 2028, and February 24, 2029. Each RSU converts into one share of Mativ common stock upon vesting, aligning a portion of the CEO’s compensation with future company performance and continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Singhal Shruti

(Last) (First) (Middle)

MATIV HOLDINGS, INC.

100 KIMBALL PLACE, STE 600

(Street)

ALPHARETTA GA 30009

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Mativ Holdings, Inc. [ MATV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSU	(1)	02/24/2026		A		125,159(1)		(1)	(1)	Common Stock	125,159	(1)	125,159	D

Explanation of Responses:

1. On February 24, 2026, the reporting person was granted 125,159 Restricted Stock Units ("RSUs") subject to time vesting. Such RSUs vest in three equal annual installments on the anniversary of the grant date (February 24, 2027, February 24, 2028, and February 24, 2029). Each RSU represents a right to receive one share of the common stock of the issuer upon vesting.

Remarks:

	/s/ Brian Park, attorney-in-fact for Shruti Singhal, principal	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Mativ (MATV) disclose for CEO Shruti Singhal?

Mativ disclosed that CEO Shruti Singhal received a grant of 125,159 Restricted Stock Units. The RSUs are time-vested equity awards, meaning they convert into common shares only as they vest over several years, tying compensation to long-term service and performance.

How many RSUs were granted to the Mativ (MATV) CEO and at what price?

The CEO of Mativ received 125,159 Restricted Stock Units at a grant price of $0.00 per unit. RSUs are typically part of compensation rather than purchased in the market, and each RSU represents a right to receive one share of common stock upon vesting.

When do Shruti Singhal’s Mativ (MATV) RSUs vest?

The 125,159 RSUs granted to Shruti Singhal vest in three equal annual installments. Vesting occurs on the grant date anniversaries of February 24, 2027, February 24, 2028, and February 24, 2029, progressively delivering shares over a three-year period.

What does each RSU granted to the Mativ (MATV) CEO represent?

Each RSU represents a right to receive one share of Mativ common stock upon vesting. As the RSUs vest over the three annual dates, they convert into actual shares, increasing the CEO’s direct equity stake in the company over time.

Is the Mativ (MATV) CEO’s RSU grant a market purchase or a compensation award?

The RSU transaction is a compensation award, not a market purchase. The Form 4 lists the code as a grant or award acquisition at a price of $0.00, consistent with equity incentives granted by the company as part of executive compensation packages.